Search results
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster | The Motley Fool
The Motley Fool· 3 days agoEli Lilly's (LLY -0.55%) name has become somewhat synonymous with its work in diabetes and obesity...
Napa Wealth Management Buys Shares of 4,545 Eli Lilly and Company (NYSE:LLY)
ETF DAILY NEWS· 2 days agoNapa Wealth Management purchased a new position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) during the 4th quarter, according to the company ...
Mounjaro Is Targeting Another Multibillion-Dollar Market: Is Eli Lilly Stock a Buy? | The Motley...
The Motley Fool· 3 days agoOccasionally, some pharmaceutical companies hit the jackpot and launch medicines worth all that...
Eli Lilly pharma company debuts new Concord digs with Gov. Cooper on hand
WJZY via Yahoo Finance· 4 days agoCONCORD, N.C. (QUEEN CITY NEWS) – North Carolina Governor Roy Cooper is in Concord Friday for the...
Mounjaro Is Targeting Another Multibillion-Dollar Market: Is Eli Lilly Stock a Buy?
Motley Fool via Yahoo Finance· 3 days agoDeveloping brand-new drugs is a long and expensive process that doesn't always deliver a positive...
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
Motley Fool via Yahoo Finance· 2 days agoIf you're eyeing an investment in Madrigal Pharmaceuticals (NASDAQ: MDGL), now's the time to imagine...
Lilly and subsidiary Point Biopharma accused of patent infringement of cancer drugs - Indianapolis...
Indianapolis Business Journal· 1 day agoEli Lilly and Co. and a biopharma company it bought last year are accused of infringing on the...
Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?
Motley Fool via Yahoo Finance· 7 days agoJohnson & Johnson reigned as the largest healthcare company in the world for years. UnitedHealth...
Eli Lilly unveils new manufacturing plant for GLP-1 pens
Yahoo Finance via AOL· 3 days agoCONCORD, N.C. — Eli Lilly (LLY) unveiled its newest manufacturing plant in Concord, N.C., Friday,...
Lilly’s Phase II results in Alzheimer’s disease have most experts saying donanemab is done
Clinical Trials Arena via Yahoo Finance· 1 day agoEli Lilly’s donanemab for early symptomatic Alzheimer’s disease (AD) has most experts dubious of the...